These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 6744266
1. Differential activity of vincristine and vinblastine against cultured cells. Ferguson PJ, Phillips JR, Selner M, Cass CE. Cancer Res; 1984 Aug; 44(8):3307-12. PubMed ID: 6744266 [Abstract] [Full Text] [Related]
3. Accumulation and release of vinblastine and vincristine by HeLa cells: light microscopic, cinematographic, and biochemical study. Lengsfeld AM, Dietrich J, Schultze-Maurer B. Cancer Res; 1982 Sep; 42(9):3798-805. PubMed ID: 7105045 [Abstract] [Full Text] [Related]
7. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells. Traganos F, Staiano-Coico L, Darzynkiewicz Z, Melamed MR. Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993 [Abstract] [Full Text] [Related]
8. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents. Chou TC, Schmid FA, Feinberg A, Philips FS, Han J. Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591 [Abstract] [Full Text] [Related]
9. Time dependence of [3H]-vincristine accumulation by L1210 mouse leukemic cells. Effect of P-glycoprotein overexpression. Breier A, Stefanková Z, Barancík M, Tribulová N. Gen Physiol Biophys; 1994 Aug; 13(4):287-98. PubMed ID: 7890145 [Abstract] [Full Text] [Related]
10. The action of two Vinca alkaloids on B16 melanoma in vitro. Donoso JA, Himes RH. Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174 [Abstract] [Full Text] [Related]
11. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells. Van Belle SJ, De Smet MC, De Mey JE, Storme GA. Anticancer Res; 1991 Jun; 11(1):465-71. PubMed ID: 2018383 [Abstract] [Full Text] [Related]
12. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells. Howard SM, Theologides A, Sheppard JR. Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211 [Abstract] [Full Text] [Related]
13. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells. Traganos F, Evenson DP, Staiano-Coico L, Darzynkiewicz Z, Melamed MR. Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553 [Abstract] [Full Text] [Related]
14. Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection. Ido M, Lagacé L, Chafouleas JG. Cancer Res; 1990 Oct 15; 50(20):6554-8. PubMed ID: 2208115 [Abstract] [Full Text] [Related]
15. Effect of phorbol myristate acetate (PMA) on P-glycoprotein mediated vincristine resistance of L1210 cells. Barancík M, Stefanková Z, Breier A. Gen Physiol Biophys; 1995 Apr 15; 14(2):171-5. PubMed ID: 8846884 [Abstract] [Full Text] [Related]
18. Adaptation of mouse leukemia cells L1210 to vincristine. Evidence for expression of P-glycoprotein. Poleková L, Barancík M, Mrázová T, Pirker R, Wallner J, Sulová Z, Breier A. Neoplasma; 1992 Apr 15; 39(2):73-7. PubMed ID: 1356238 [Abstract] [Full Text] [Related]
19. Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. Nederman T. Cancer Res; 1984 Jan 15; 44(1):254-8. PubMed ID: 6690037 [Abstract] [Full Text] [Related]
20. Sustained intracellular retention of dolastatin 10 causes its potent antimitotic activity. Verdier-Pinard P, Kepler JA, Pettit GR, Hamel E. Mol Pharmacol; 2000 Jan 15; 57(1):180-7. PubMed ID: 10617693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]